Skip to main content

Table 2 Logistic regression models: (1) treatment completion; and (2) return for SVR12 testing

From: Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City

Predictor Treatment completion Return for SVR 12
OR 95% CI OR 95% CI
Age 1 0.9–1.0 1 0.97–1.03
Female 0.8 0.3–2.3 0.6 0.3–1.2
Ethnicity
White Reference    
Black or African-American 1.1 0.2–4.8 0.7 0.3–1.8
Hispanic 0.6 0.2–2.1 0.7 0.3–1.4
Other 0.8 0.2–3.3 0.9 0.3–2.3
Uses medicaid 0.7 0.2–2.5 0.3 0.10.7
Cirrhosis 0.8 0.3–2.3 2 0.9–4.8
Diabetes 1.4 0.3–5.5 2.5 0.9–7.2
Other comorbidity 1.2 0.5–2.9 1.5 0.8–2.7
Current substance use 0.8 0.3–2.2 1 0.5–1.9
Current psychiatric Illness 0.9 0.4–2.2 1.6 0.8–3.3
Lifetime substance use 2.1 0.3–13.7 0.5 0.1–2.5
Lifetime psychiatric Illness 1.3 0.2–6.6 1.6 0.5–4.8
Incarceration history
Never Reference    
 < 5 years ago 0.6 0.2–2.1 1.3 0.5–3.2
 > 5 years ago 1.1 0.3–3.5 0.9 0.4–2.0
Methadone use 0.6 0.2–2.1 0.5 0.2–1.1
Unstable housing status 0.3 0.10.9 1.2 0.6–2.4
  1. *Statistically significant findings bolded